Karin Birkenkamp-Demtröder

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Cancer Biology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Sia Viborg Lindskrog

Aarhus University

DENMARK

View details

Tenna Henriksen

Aarhus University

DENMARK

View details

Jakob S Pedersen

Aarhus University

DENMARK

View details

Jørgen Bjerggaard Jensen

Aarhus University

DENMARK

View details

Lars Dyrskjøt

Aarhus University Hospital

DENMARK

View details

Amanda Frydendahl

Aarhus University

DENMARK

View details

Asbjørn Kjær

Aarhus University

DENMARK

View details

Margaret Knowles

University of Leeds

UNITED KINGDOM

View details

Iver Kristiansen Nordentoft

Associate Professor

Aarhus Universitetshospital

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Karin Birkenkamp-Demtröder

Research Interests

Explore related searches

Contact this professor

Articles (10)

Cell-free urine- and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer

Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer

Accuracy of genome-wide mutational analysis for tumor-informed ctDNA-guided MRD monitoring in bladder cancer.

Utility of ctDNA in predicting outcome and pathological complete response in patients with bladder cancer as a guide for selective bladder preservation strategies.

Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non-muscle-invasive Bladder Cancer.

Differential RNA aptamer affinity profiling on plasma as a potential diagnostic tool for bladder cancer

<i>SPTAN1</i>, <i>APC</i>, <i>and FGFR3</i> Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer.

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA.

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.

Collaborators (9)

Sia Viborg Lindskrog

Tenna Henriksen

Jakob S Pedersen

Jørgen Bjerggaard Jensen

Lars Dyrskjøt

Amanda Frydendahl

Asbjørn Kjær

Margaret Knowles

Iver Kristiansen Nordentoft

Make your next move.